ICS is developing the most complete comprehensive solution to embolic protection for TAVR and other left-side heart procedures.

LifeVoxel.AI’s patented, cloud-based technology enables technicians and physicians to view and assess images remotely without the need for proprietary platforms, and with zero latency. This helps to eliminate the need for travel or physically accessing medical facilities, which will become increasingly important in the post-COVID-19 era, as more medical facilities will increasingly limit access. 

Vasorum has developed and received CE Mark and FDA PMA approval for Celt ACD® (Arterial Closure Device). The device is available in 5F, 6F and 7F sizes for use in the interventional cardiology and radiology markets.